Taken together, our study has demonstrated that USP22 is a novel co-regulator of ZEB1 to enhance ZEB1-induced VEGFA transcription via USP22 deubiquitination activity, thereby promoting tumor growth/invasion/VM formation and angiogenesis in HCC. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.